Utilization of Target Ranges to Treat Parkinson's Disease With the PKG
Public ClinicalTrials.gov record NCT03984305. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Utilization of Target Ranges to Treat Patients With Parkinson's Disease by Objective Measurement Using the Personal KinetiGraph® (PKG®) Compared to Standard of Care Assessment (TARGET-PD)- A Randomized Controlled Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main objective of this study is to evaluate whether people whose PD symptoms are uncontrolled who are managed with the aid of objective measurement and use of target ranges have improved PD symptoms and outcomes as compared to individuals treated using only standard of care (medical history, neurological examination).
Study identification
- NCT ID
- NCT03984305
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 41 participants
Conditions and interventions
Conditions
Interventions
Device
Eligibility (public fields only)
- Age range
- 46 Years to 83 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 15, 2019 (Actual)
- Primary completion
- Oct 16, 2020 (Actual)
- Completion
- Oct 16, 2020 (Actual)
- Last update posted
- Feb 8, 2022
2019 – 2020
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Washington Regional Medical Center | Fayetteville | Arkansas | 72703 | — |
| University of Arkansas Medical Center | Little Rock | Arkansas | 72205 | — |
| Parkinson's Disease and Movement Disorders Center of Silicon Valley | Menlo Park | California | 94025 | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton | Florida | 33486 | — |
| University of Florida | Gainesville | Florida | 32608 | — |
| University of South Florida | Tampa | Florida | 33612 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Kaiser Mid-Atlantic Permanente Center | Rockville | Maryland | 20852 | — |
| Neurology Center of New England | Foxborough | Massachusetts | 02035 | — |
| Michigan State University | East Lansing | Michigan | 48824 | — |
| University of Nebraska | Omaha | Nebraska | 68198 | — |
| Cleveland Clinic Lou Ruvo Center for Brain Health | Las Vegas | Nevada | 89106 | — |
| Parkinson's Disease and Movement Disorders Center of Long Island | Commack | New York | 11725 | — |
| Weill Cornell | New York | New York | 10021 | — |
| University of Texas | Houston | Texas | 77030 | — |
| Marshall University | Huntington | West Virginia | 25701 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03984305, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2022 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03984305 live on ClinicalTrials.gov.